Madhya Pradesh varsity to develop Ayurvedic medicine using nano-technology

In a first, taking cue from tie-ups of the Council of Scientific and Industrial Research (CSIR) and Defence Research and Development Organisation (DRDO), a Madhya Pradesh government-funded university is set to develop new Ayurveda-based medicine formulas using nano-technology and market remedies for incurable diseases. Jiwaji University has signed an agreement with a Delhi-based pharmaceutical company to study centuries-old ayurvedic formulations, standardise and authenticate them and use information about their potent ingredients for developing new medicines.

"Ayurveda is the key to treating some of the incurable diseases. If old formulations are subjected to modern research, we will surely be able to develop world-class medicines with negligible side effects," said Dr VM Katoch, Former Director General ICMR.

Highlighting gains from tie-ups between researchers and industry, he cited the example of a DRDO-developed formulation to treat white skin spots or Vitiligo, Lukoskin, and CSIR-developed diabetes formulation called BGR-34. "The Union government has tied-up with AIMIL pharmaceuticals for marketing the two drugs which have made a huge impact in the lives of suffering masses throughout the country," said Dr Katoch who was present at the event to sign the agreement.

The CSIR has developed BGR-34 after standardisation and pre-clinical studies conducted jointly by its two labs — Central Institute of Medicinal and Aromatic Plants (CIMAP) and National Botanical Research Institute (NBRI). It is meant to be used by newly diagnosed diabetes patients for management of the disease. Launched two years ago, BGR-34, is an add-on or adjuvant, based on six herbal plants, to existing diabetes treatment helping to maintain normal blood glucose levels. It also helps in improving immune system, releasing antioxidants and checking free radicals.

"AIMIL will pump in resources, like equipment and technology inputs, to help the university utilise its pool of qualified researchers to its optimal potential," said Sanchit Sharma, AIMIL executive director.

With an aim to benefit the patients suffering from non-communicable diseases like diabetes, the Modi Government has launched a pilot project integrating allopathic and traditional medicines in its hospitals. Ayush minister Shripad Naik said in Parliament recently that the government is not only batting for the integration of alternative traditional medicines, but also promoting research in the sector.